847358-98-9Relevant articles and documents
Identification of potent and reversible cruzipain inhibitors for the treatment of Chagas disease
Beaulieu, Christian,Isabel, Elise,Fortier, Angélique,Massé, Frédéric,Mellon, Christophe,Méthot, Nathalie,Ndao, Momar,Nicoll-Griffith, Deborah,Lee, Doris,Park, Hyeram,Black, W. Cameron
scheme or table, p. 7444 - 7449 (2011/02/23)
Identification of potent and reversible cruzipain inhibitors for the treatment of Chagas disease is described. The identified inhibitors bearing an amino nitrile warhead in P1 exhibit low nanomolar in vitro potency against cruzipain. Further SAR in P2 por
CATHEPSIN CYSTEINE PROTEASE INHIBITORS
-
Page/Page column 49, (2010/02/11)
This invention relates to a novel class of compounds, represented by the formula below, wherein the meanings of G, E, E, n, R1, R2, R3 et R4 are indicated therein, which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.
CATHEPSIN CYSTEINE PROTEASE INHIBITORS
-
Page/Page column 41-42, (2010/02/12)
This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.